Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial

Ahmad, HA, Baker, JF, Østergaard, M et al. (3 more authors) (2019) Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial. Advances in Therapy, 36 (9). pp. 2384-2393. ISSN 0741-238X

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Keywords: Biological therapies; DMARDs; Inflammation; Magnetic resonance imaging; Rheumatoid arthritis; Rhuematology
Dates:
  • Accepted: 18 June 2019
  • Published (online): 5 July 2019
  • Published: September 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Musculoskeletal Medicine & Imaging (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 20 Jun 2019 10:34
Last Modified: 15 Aug 2019 11:09
Status: Published
Publisher: Springer
Identification Number: https://doi.org/10.1007/s12325-019-01020-6

Share / Export

Statistics